Last updated: April 22, 2024
Sponsor: Centre Hospitalier Intercommunal Creteil
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pharyngitis
Throat And Tonsil Infections
Strep Throat
Treatment
Index test: Abbott ID NOW STREP A 2
Comparator test: Rapid antigen detection test (usual care)
Reference standard test: Composite of culture and PCR-based tests based on a throat swab
Clinical Study ID
NCT05521568
PREDISTREP IX
Ages 3-15 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- children 3-15 years
- seen in primary care (general practitioner or primary care pediatrician)
- with a diagnosis of acute pharyngitis defined as an inflammation of the pharynx and/ortonsils (erythema with or without exudate) or acute sore throat (even if without localsigns of pharyngeal inflammation)
- non-opposition of the accompanying parent(s)
Exclusion
Exclusion Criteria:
- children who received antibiotics within 7 days before inclusion
- children already enrolled in the study for the same episode of pharyngitis
Study Design
Total Participants: 800
Treatment Group(s): 3
Primary Treatment: Index test: Abbott ID NOW STREP A 2
Phase:
Study Start date:
January 31, 2023
Estimated Completion Date:
February 28, 2025
Study Description
Connect with a study center
WOLLNER
Nogent-sur-Marne, 94130
FranceSite Not Available
TOUITOU
Paris, 75012
FranceSite Not Available
ACTIV
Saint-Maur-des-Fossés,
FranceActive - Recruiting
Partouche
Saint-Ouen, 93400
FranceSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.